A vision becomes reality
For a long time, it sounded like a dream that couldn't come true. But through tissue engineering, medicine is now able to replace diseased or destroyed tissue with artificially-created biological tissue. B. Braun is one of the leading medical device manufacturer in this procedure: The body's own cartilage cells are removed and cloned in the laboratory for transplantation. Then, the cells are transplanted into the joint, where they start to produce new cartilage matrices. The body regenerates naturally.
Achievements in healthcare and maximum medical performance
Hans Jürgen Leitner benefits from this "self-healing". After years as a high-performing sportsperson, the former Taekwondo champion and trainer was suffering from cartilage damage. It looked like he would have to give up his sport. But through sheer force of will and the support of the minimally invasive procedure for treating damaged cartilage Leitner is embarking on a new phase of his life, continuing to do sport, but nearly without the pain. And now a particular dream of his has come true: a Taekwondo school of his own.
Interdisciplinary, from start to finish
For employees of TETEC AG, a subsidiary of B. Braun, Hans Jürgen Leitner is living proof of the effectiveness of the developed procedure for restoring body’s own cartilage. A medical masterpiece – no surprise given the large number of experts who are involved in its development. The TETEC team at the Reutlingen location covers not only the Research and Development, Production, Quality Control and Approval departments, but also includes doctors, cellular and molecular biologists, pharmacologists, biochemists and technical assistants. On the principle of close teamwork, they guarantee that products are developed, tested and produced at an outstanding level.
Biotechnology – a field with potential
Our colleagues at TETEC AG are convinced that tissue engineering will revolutionize the replacement of tissue and organs. Research and Development will open up entirely new treatment options, in order to support people like Hans Jürgen Leitner on their path to physical capability and good health. Regenerative medicine is also forward-looking from an economic perspective: the procedures involved drive innovation and will gradually replace or supplement conventional treatment procedures.
